Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Marinus Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Marinus Pharmaceuticals

Marinus Pharmaceuticals

Public

US-based Marinus Pharmaceuticals develops and commercializes medical drugs for serious neurological and psychiatric disorders.

HQ
Radnor, PA, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Founded in Radnor, United States, Marinus Pharmaceuticals is dedicated to developing and commercializing medical drugs aimed at treating serious neurological and psychiatric disorders, including epilepsy, post-traumatic stress disorder, and fragile-X syndrome. The company’s core mission is to drastically improve the lives of patients affected by seizure disorders through mindful innovation and a compassionate approach to medicine.

Notable figures associated with Marinus Pharmaceuticals include a passionate team of experts committed to patient-centric innovation. The company has achieved significant milestones in the development of therapies for rare and challenging conditions, contributing to the broader medical community's understanding and treatment of these disorders. Marinus Pharmaceuticals' impact is evident in its dedication to transforming medicine and creating a better future for patients and their families.

Marinus Pharmaceuticals - Similar Companies

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Marius Pharmaceuticals logo

Marius Pharmaceuticals

mariuspharma.com

Sea Pharmaceuticals logo

Sea Pharmaceuticals

Aptinyx logo

Aptinyx

aptinyx.com

Confluence Pharmaceuticals logo

Confluence Pharmaceuticals

Acadia Pharmaceuticals logo

Acadia Pharmaceuticals

acadia-pharm.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Minerva Neurosciences logo

Minerva Neurosciences

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

BioMarin logo

BioMarin

biomarin.com

Harmony Biosciences logo

Harmony Biosciences

NeuroPro Therapeutics logo

NeuroPro Therapeutics

Marinus Pharmaceuticals - Quick Facts

Who are Marinus Pharmaceuticals' competitors?

Companies similar to Marinus Pharmaceuticals include Supernus Pharmaceuticals, Marius Pharmaceuticals, Sea Pharmaceuticals and Aptinyx.

When was Marinus Pharmaceuticals founded?

Marinus Pharmaceuticals was founded in 2003.

Where is Marinus Pharmaceuticals' headquarters located?

Marinus Pharmaceuticals' headquarters is located in Radnor, PA, US.

When was Marinus Pharmaceuticals' last funding round?

Marinus Pharmaceuticals' most recent funding round was for $60M (USD) in November 2022.

How much has Marinus Pharmaceuticals raised to-date?

As of Nov 7, 2022, Marinus Pharmaceuticals has raised a total of $406.9M (USD).

How many employees does Marinus Pharmaceuticals have?

Marinus Pharmaceuticals has 151 employees as of Feb 6, 2024.

Marinus Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Drugs
Tags
  • Healthtech
  • Pharmaceutical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods